Your browser doesn't support javascript.
loading
Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for Waldenström's Macroglobulinemia.
Dogliotti, Irene; Jiménez, Cristina; Varettoni, Marzia; Talaulikar, Dipti; Bagratuni, Tina; Ferrante, Martina; Pérez, José; Drandi, Daniela; Puig, Noemí; Gilestro, Milena; García-Álvarez, María; Owen, Roger; Jurczak, Wojciech; Tedeschi, Alessandra; Leblond, Veronique; Kastritis, Efstathios; Kersten, Marie José; D'Sa, Shirley; Kascák, Michal; Willenbacher, Wolfgang; Roccaro, Aldo M; Poulain, Stephanie; Morel, Pierre; Kyriakou, Charalampia; Fend, Falko; Vos, Josephine M I; Dimopoulos, Meletios A; Buske, Christian; Ferrero, Simone; García-Sanz, Ramón.
Afiliação
  • Dogliotti I; Unit of Hematology, Department of Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • Jiménez C; Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (University of Salamanca-CSIC), Salamanca, Spain. jscris@usal.es.
  • Varettoni M; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Talaulikar D; Canberra Health Services, College of Medicine, Biology and Environment Australian National University, Canberra ACT, Australia.
  • Bagratuni T; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Ferrante M; Unit of Hematology, Department of Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • Pérez J; Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (University of Salamanca-CSIC), Salamanca, Spain.
  • Drandi D; Unit of Hematology, Department of Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • Puig N; Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (University of Salamanca-CSIC), Salamanca, Spain.
  • Gilestro M; Unit of Hematology, Department of Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • García-Álvarez M; Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (University of Salamanca-CSIC), Salamanca, Spain.
  • Owen R; The Leeds Teaching Hospitals National Health Service Trust, Leeds, UK.
  • Jurczak W; Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland.
  • Tedeschi A; ASST Grande Ospedale Metropolitano Niguarda Hospital, Milan, Italy.
  • Leblond V; Département d'Hématologie Hôpital Pitié-Salpêtrière APHP, UPMC Université Paris, Paris, France.
  • Kastritis E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Kersten MJ; National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • D'Sa S; Department of Hematology, Amsterdam UMC, Location University of Amsterdam, Cancer Center Amsterdam and LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands.
  • Kascák M; Centre for Waldenströms Macroglobulinaemia and Related Conditions, University College London Hospitals National Health Service Foundation Trust, London, UK.
  • Willenbacher W; Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Roccaro AM; Department of Haematology and Oncology, Internal Medicine V, Innsbruck University Hospital & Syndena GmbH, Connect to Cure, Innsbruck, Austria.
  • Poulain S; Clinical Research Development and Phase I Unit, ASST Spedali Civili di Brescia, Brescia, Italy.
  • Morel P; Laboratory of Hematology, Biology and Pathology Center, CHU of Lille, INSERM UMR-S 1277, Team 4, Oncolille, Lille, France.
  • Kyriakou C; Service d'Hematologie Clinique et Therapie Cellulaire, Centre Hospitalier Universitaire d'Amiens-Picardie, Amiens, France.
  • Fend F; Centre for Waldenströms Macroglobulinaemia and Related Conditions, University College London Hospitals National Health Service Foundation Trust, London, UK.
  • Vos JMI; Institute of Pathology and Comprehensive Cancer Centre, Eberhard-Karls-University, University Hospital Tübingen, Tübingen, Germany.
  • Dimopoulos MA; Department of Hematology, Amsterdam UMC, Location University of Amsterdam, Cancer Center Amsterdam and LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands.
  • Buske C; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Ferrero S; National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • García-Sanz R; Institute of Experimental Cancer Research, Comprehensive Cancer Center Ulm, University Hospital of Ulm, Ulm, Germany.
Leukemia ; 37(2): 388-395, 2023 02.
Article em En | MEDLINE | ID: mdl-36435884
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Macroglobulinemia de Waldenstrom Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Macroglobulinemia de Waldenstrom Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália